Abstract
Understanding molecular mechanisms involved in atrial tissue remodeling and arrhythmogenesis in atrial fibrillation (AF) is essential for developing specific therapeutic approaches. Two-pore-domain potassium (K2P) channels modulate cellular excitability, and TASK-1 (K2P3.1) currents were recently shown to alter atrial action potential duration in AF and heart failure (HF). Finding animal models of AF that closely resemble pathophysiological alterations in human is a challenging task. This study aimed to analyze murine cardiac expression patterns of K2P channels and to assess modulation of K2P channel expression in murine models of AF and HF. Expression of cardiac K2P channels was quantified by real-time qPCR and immunoblot in mouse models of AF [cAMP-response element modulator (CREM)-IbΔC-X transgenic animals] or HF (cardiac dysfunction induced by transverse aortic constriction, TAC). Cloned murine, human, and porcine TASK-1 channels were heterologously expressed in Xenopus laevis oocytes. Two-electrode voltage clamp experiments were used for functional characterization. In murine models, among members of the K2P channel family, TASK-1 expression displayed highest levels in both atrial and ventricular tissue samples. Furthermore, K2P2.1, K2P5.1, and K2P6.1 showed significant expression levels. In CREM-transgenic mice, atrial expression of TASK-1 was significantly reduced in comparison with wild-type animals. In a murine model of TAC-induced pressure overload, ventricular TASK-1 expression remained unchanged, while atrial TASK-1 levels were significantly downregulated. When heterologously expressed in Xenopus oocytes, currents of murine, porcine, and human TASK-1 displayed similar characteristics. TASK-1 channels display robust cardiac expression in mice. Murine, porcine, and human TASK-1 channels share functional similarities. Dysregulation of atrial TASK-1 expression in murine AF and HF models suggests a mechanistic contribution to arrhythmogenesis.
Similar content being viewed by others
Abbreviations
- A:
-
Atrium
- AF:
-
Atrial fibrillation
- APD:
-
Action potential duration
- AVN:
-
Atrioventricular node
- CASQ:
-
Calsequestrin
- CaV:
-
Voltage-gated calcium channel
- CREM:
-
CAMP-response element modulator
- GAPDH:
-
Glyceraldehyde 3-phosphate dehydrogenase
- HF:
-
Heart failure
- IPO8:
-
Importin 8
- K2P :
-
Two-pore-domain potassium channel
- Kcnip2:
-
Voltage-gated potassium channel interacting protein 2
- Kir:
-
Potassium inward rectifier
- KV :
-
Voltage-gated potassium channel
- LA:
-
Left atrium
- LAA:
-
Left atrial appendage
- m:
-
Murine
- M-mode:
-
Motion mode
- NaV :
-
Voltage-gated sodium channel
- RA:
-
Right atrium
- RAA:
-
Right atrial appendage
- RVOT:
-
Right ventricular outflow tract
- RYR:
-
Ryanodine receptor
- SAN:
-
Sinoatrial node
- SR:
-
Sinus rhythm
- SUR:
-
Sulfonylurea receptor
- TAC:
-
Transverse aortic constriction
- TALK:
-
TWIK-related alkaline pH-activated K+ channel
- TASK:
-
TWIK-related acid-sensitive K+ channel
- TG:
-
Transgene
- THIK:
-
Tandem pore domain in a halothane-inhibited K+ channel
- TRAAK:
-
TWIK-related arachidonic acid-stimulated K+ channel
- TREK:
-
TWIK-related K+ channel
- TRESK:
-
TWIK-related spinal cord K+ channel
- TWIK:
-
Tandem of pore domains in a weak inward rectifying channel
- V:
-
Ventricle
References
Arnold K, Bordoli L, Kopp J, Schwede T (2006) The SWISS-MODEL Workspace: a web-based environment for protein structure homology modelling. Bioinformatics 22:195–201. https://doi.org/10.1093/bioinformatics/bti770
Biasini M, Bienert S, Waterhouse A, Arnold K, Studer G, Schmidt T, Kiefer F, Cassarino TG, Bertoni M, Bordoli L, Schwede T (2014) SWISS-MODEL: modelling protein tertiary and quaternary structure using evolutionary information. Nucleic Acids Res 42:W252–W258. https://doi.org/10.1093/nar/gku340
Brohawn SG, del Mármol J, MacKinnon R (2012) Crystal structure of the human K2P TRAAK, a lipid- and mechano-sensitive K+ ion channel. Science 335:436–441. https://doi.org/10.1126/science.1213808
Dereeper A, Audic S, Claverie JM, Blanc G (2010) BLAST-EXPLORER helps you building datasets for phylogenetic analysis. BMC Evol Biol 10:8. https://doi.org/10.1186/1471-2148-10-8
Dereeper A, Guignon V, Blanc G, Audic S, Buffet S, Chevenet F, Dufayard JF, Guindon S, Lefort V, Lescot M, Claverie JM, Gascuel O (2008) Phylogeny.fr: robust phylogenetic analysis for the non-specialist. Nucleic Acids Res 36:W465–W469. https://doi.org/10.1093/nar/gkn180
Deshmukh A, Barnard J, Sun H, Newton D, Castel L, Pettersson G, Johnston D, Roselli E, Gillinov AM, McCurry K, Moravec C, Smith JD, Van Wagoner DR, Chung MK (2015) Left atrial transcriptional changes associated with atrial fibrillation susceptibility and persistence. Circ Arrhythm Electrophysiol 8:32–41. https://doi.org/10.1161/CIRCEP.114.001632
Enyedi P, Czirják G (2010) Molecular background of leak K+ currents: two-pore domain potassium channels. Physiol Rev 90:559–605. https://doi.org/10.1152/physrev.00029.2009
Feliciangeli S, Chatelain FC, Bichet D, Lesage F (2015) The family of K2P channels: salient structural and functional properties. J Physiol 593:2587–2603. https://doi.org/10.1113/jphysiol.2014.287268
Friedrich C, Rinne S, Zumhagen S, Kiper AK, Silbernagel N, Netter MF, Stallmeyer B, Schulze-Bahr E, Decher N (2014) Gain-of-function mutation in TASK-4 channels and severe cardiac conduction disorder. EMBO Mol Med 6:937–951. https://doi.org/10.15252/emmm.201303783
Goette A, Kalman JM, Aguinaga L, Akar J, Cabrera JA, Chen SA, Chugh SS, Corradi D, D’Avila A, Dobrev D, Fenelon G, Gonzalez M, Hatem SN, Helm R, Hindricks G, Ho SY, Hoit B, Jalife J, Kim YH, Lip GY, Ma CS, Marcus GM, Murray K, Nogami A, Sanders P, Uribe W, Van Wagoner DR, Nattel S (2017) EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: definition, characterization, and clinical implication. Heart Rhythm 14:e3–e40. https://doi.org/10.1016/j.hrthm.2016.05.028
Goldstein SAN, Bayliss DA, Kim D, Lesage F, Plant LD, Rajan S (2005) International Union of Pharmacology. LV. Nomenclature and molecular relationships of two-P potassium channels. Pharmacol Rev 57:527–540. https://doi.org/10.1124/pr.57.4.12
Goldstein SAN, Bockenhauer D, O’Kelly I, Zilberberg N (2001) Potassium leak channels and the KCNK family two-P-domain subunits. Nat Rev Neurosci 2:175–184. https://doi.org/10.1038/35058574
Gore-Panter SR, Rennison JH, Van Wagoner DR (2017) Genetic-genomic insights into the metabolic determinants of spontaneous atrial fibrillation. Circ Arrhythm Electrophysiol. 10:e005636. https://doi.org/10.1161/CIRCEP.117.005636
Guex N, Peitsch MC, Schwede T (2009) Automated comparative protein structure modeling with SWISS-MODEL and Swiss-PdbViewer: a historical perspective. Electrophoresis 30:S162–S173. https://doi.org/10.1002/elps.200900140
Kiefer F, Arnold K, Künzli M, Bordoli L, Schwede T (2009) The SWISS-MODEL repository and associated resources. Nucleic Acids Res 37:D387–D392. https://doi.org/10.1007/978-1-60761-977-2_3
Kim GE, Ross JL, Xie C, Su KN, Zaha VG, Wu X, Palmeri M, Ashraf M, Akar JG, Russell KS, Akar FG, Young LH (2015) LKB1 deletion causes early changes in atrial channel expression and electrophysiology prior to atrial fibrillation. Cardiovasc Res 108:197–208. https://doi.org/10.1093/cvr/cvv212
Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B, Castella M, Diener HC, Heidbuchel H, Hendriks J, Hindricks G, Manolis AS, Oldgren J, Popescu BA, Schotten U, Van Putte B, Vardas P, Agewall S, Camm J, Baron Esquivias G, Budts W, Carerj S, Casselman F, Coca A, De Caterina R, Deftereos S, Dobrev D, Ferro JM, Filippatos G, Fitzsimons D, Gorenek B, Guenoun M, Hohnloser SH, Kolh P, Lip GY, Manolis A, McMurray J, Ponikowski P, Rosenhek R, Ruschitzka F, Savelieva I, Sharma S, Suwalski P, Tamargo JL, Taylor CJ, Van Gelder IC, Voors AA, Windecker S, Zamorano JL, Zeppenfeld K (2016) 2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J 37:2893–2962. https://doi.org/10.1093/eurheartj/ehw210
Kirchhof P, Kahr PC, Kaese S, Piccini I, Vokshi I, Scheld HH, Rotering H, Fortmueller L, Laakmann S, Verheule S, Schotten U, Fabritz L, Brown NA (2011) PITX2c is expressed in the adult left atrium, and reducing Pitx2c expression promotes atrial fibrillation inducibility and complex changes in gene expression. Circ Cardiovasc Genet 4:123–133. https://doi.org/10.1161/CIRCGENETICS.110.958058
Kirchhof P, Marijon E, Fabritz L, Li N, Wang W, Wang T, Schulte K, Hanstein J, Schulte JS, Vogel M, Mougenot N, Laakmann S, Fortmueller L, Eckstein J, Verheule S, Kaese S, Staab A, Grote-Wessels S, Schotten U, Moubarak G, Wehrens XH, Schmitz W, Hatem S, Müller FU (2013) Overexpression of cAMP-response element modulator causes abnormal growth and development of the atrial myocardium resulting in a substrate for sustained atrial fibrillation in mice. Int J Cardiol 166:366–374. https://doi.org/10.1016/j.ijcard.2011.10.057
Li N, Chiang DY, Wang S, Wang Q, Sun L, Voigt N, Respress JL, Ather S, Skapura DG, Jordan VK, Horrigan FT, Schmitz W, Müller FU, Valderrabano M, Nattel S, Dobrev D, Wehrens XHT (2014) Ryanodine receptor-mediated calcium leak drives progressive development of an atrial fibrillation substrate in a transgenic mouse model. Circulation 129:1276–1285. https://doi.org/10.1161/CIRCULATIONAHA.113.006611
Liang B, Soka M, Christensen AH, Olesen MS, Larsen AP, Knop FK, Wang F, Nielsen JB, Andersen MN, Humphreys D, Mann SA, Huttner IG, Vandenberg JI, Svendsen JH, Haunsø S, Preiss T, Seebohm G, Olesen SP, Schmitt N, Fatkin D (2014) Genetic variation in the two-pore domain potassium channel, TASK-1, may contribute to an atrial substrate for arrhythmogenesis. J Mol Cell Cardiol 67:69–76. https://doi.org/10.1016/j.yjmcc.2013.12.014
Lugenbiel P, Wenz F, Syren P, Geschwill P, Govorov K, Seyler C, Frank D, Schweizer PA, Franke J, Weis T, Bruehl C, Schmack B, Ruhparwar A, Karck M, Frey N, Katus HA, Thomas D (2017) TREK-1 (K2P2.1) K+ channels are suppressed in patients with atrial fibrillation and heart failure and provide therapeutic targets for rhythm control. Basic Res Cardiol 112:8. https://doi.org/10.1007/s00395-016-0597-7
Ma L, Roman-Campos D, Austin ED, Eyries M, Sampson KS, Soubrier F, Germain M, Trégouet DA, Borczuk A, Rosenzweig EB, Girerd B, Montani D, Humbert M, Loyd JE, Kass RS, Chung WK (2013) A novel channelopathy in pulmonary arterial hypertension. N Engl J Med 369:351–361. https://doi.org/10.1056/NEJMoa1211097
Mueller FU, Lewin G, Baba HA, Bokník P, Fabritz L, Kirchhefer U, Kirchhof P, Loser K, Matus M, Neumann J, Riemann B, Schmitz W (2005) Heart-directed expression of a human cardiac isoform of cAMP-response element modulator in transgenic mice. J Biol Chem 280:6906–6914. https://doi.org/10.1074/jbc.M407864200
Riley G, Syeda F, Kirchhof P, Fabritz L (2012) An introduction to murine models of atrial fibrillation. Front Physiol 3:296. https://doi.org/10.3389/fphys.2012.00296
Schmidt C, Wiedmann F, Kallenberger SM, Ratte A, Schulte J, Scholz B, Müller FU, Voigt N, Zafeirioue M-P, Ehrlich JR, Tochtermann U, Veres G, Ruhparwar A, Karck M, Katus HA, Thomas D (2017) Stretch-activated two-pore-domain (K2P) potassium channels in the heart: focus on atrial fibrillation and heart failure. Prog Biophys Mol Biol 130:233–243. https://doi.org/10.1016/j.pbiomolbio.2017.05.004
Schmidt C, Wiedmann F, Langer C, Tristram F, Anand P, Wenzel W, Lugenbiel P, Schweizer P, Katus HA, Thomas D (2014) Cloning, functional characterization and remodeling of K2P3.1 (TASK-1) potassium channels in a porcine model of atrial fibrillation and heart failure. Heart Rhythm 11:1798–1805. https://doi.org/10.1016/j.hrthm.2014.06.020
Schmidt C, Wiedmann F, Schweizer PA, Katus HA, Thomas D (2012) Kardiale Zwei-Porendomänen Kaliumkanäle (K2P): physiologie, Pharmakologie und therapeutisches Potential. Dtsch Med Wochenschr 137:1654–1658. https://doi.org/10.1055/s-0032-1305216
Schmidt C, Wiedmann F, Schweizer PA, Katus HA, Thomas D (2014) Inhibition of cardiac two-pore-domain K+ (K2P) channels—an emerging antiarrhythmic concept. Eur J Pharmacol 738:250–255. https://doi.org/10.1016/j.ejphar.2014.05.056
Schmidt C, Wiedmann F, Tristram F, Anand P, Wenzel W, Lugenbiel P, Schweizer P, Katus HA, Thomas D (2013) Cardiac expression and atrial fibrillation-associated remodeling of K2P2.1 (TREK-1) K+ channels in a porcine model. Life Sci S0024–3205:753–754. https://doi.org/10.1016/j.lfs.2013.12.006
Schmidt C, Wiedmann F, Voigt N, Zhou XB, Heijman J, Lang S, Albert V, Kallenberger S, Ruhparwar A, Szabó G, Kallenbach K, Karck M, Borggrefe M, Biliczki P, Ehrlich JR, Baczkó I, Lugenbiel P, Schweizer PA, Donner BC, Katus HA, Dobrev D, Thomas D (2015) Upregulation of K2P3.1 K+ current causes action potential shortening in patients with chronic atrial fibrillation. Circulation 132:82–92. https://doi.org/10.1161/CIRCULATIONAHA.114.012657
Schmidt C, Wiedmann F, Zhou XB, Heijman J, Voigt N, Ratte A, Lang S, Kallenberger SM, Campana C, Weymann A, De Simone R, Szabo G, Ruhparwar A, Kallenbach K, Karck M, Ehrlich JR, Baczkó I, Borggrefe M, Ravens U, Dobrev D, Katus HA, Thomas D (2017) Inverse remodelling of K2P3.1 K+ channel expression and action potential duration in left ventricular dysfunction and atrial fibrillation: implications for patient-specific antiarrhythmic drug therapy. Eur Heart J 38:1764–1774. https://doi.org/10.1093/eurheartj/ehw559
Schotten U, Verheule S, Kirchhof P, Goette A (2009) Pathophysiological mechanisms of atrial fibrillation: a translational appraisal. Physiol Rev 91:265–325. https://doi.org/10.1152/physrev.00031.2009
Schulte JS, Fehrmann E, Tekook MA, Kranick D, Fels B, Li N, Wehrens XH, Heinick A, Seidl MD, Schmitz W, Müller FU (2016) Cardiac expression of the CREM repressor isoform CREM-IbΔC-X in mice leads to arrhythmogenic alterations in ventricular cardiomyocytes. Basic Res Cardiol 111:15. https://doi.org/10.1007/s00395-016-0532
Seidl MD, Stein J, Hamer S, Pluteanu F, Scholz B, Wardelmann E, Huge A, Witten A, Stoll M, Hammer E, Völker U, Müller FU (2017) Characterization of the genetic program linked to the development of atrial fibrillation in CREM-IbΔC-X mice. Circ Arrhythm Electrophysiol 10:e005075. https://doi.org/10.1161/CIRCEP.117.005075
Seth M, Zhang ZS, Mao L, Graham V, Burch J, Stiber J, Tsiokas L, Winn M, Abramowitz J, Rockman HA, Birnbaumer L, Rosenberg P (2009) TRPC1 channels are critical for hypertrophic signaling in the heart. Circ Res 105:1023–1030. https://doi.org/10.1161/CIRCRESAHA.109.206581
Sievers F, Wilm A, Dineen DG, Gibson TJ, Karplus K, Li W, Lopez R, McWilliam H, Remmert M, Söding J, Thompson JD, Higgins DG (2011) Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega. Mol Syst Biol 7:539. https://doi.org/10.1038/msb.2011.75
Toischer K, Rokita AG, Unsöld B, Zhu W, Kararigas G, Sossalla S, Reuter SP, Becker A, Teucher N, Seidler T, Grebe C, Preuss L, Gupta SN, Schmidt K, Lehnart SE, Krüger M, Linke WA, Backs J, Regitz-Zagrosek V, Schäfer K, Field LJ, Maier LS, Hasenfuss G (2010) Differential cardiac remodeling in preload versus afterload. Circulation 122:993–1003. https://doi.org/10.1074/jbc.M407864200
Vettel C, Lindner M, Dewenter M, Lorenz K, Schanbacher C, Riedel M, Lammle S, Meinecke S, Mason FE, Sossalla S, Geerts A, Hoffmann M, Wunder F, Brunner FJ, Wieland T, Mehel H, Karam S, Lechêne P, Leroy J, Vandecasteele G, Wagner M, Fischmeister R, El-Armouche A (2017) Phosphodiesterase 2 protects against catecholamine-induced arrhythmia and preserves contractile function after myocardial infarction. Circ Res 120:120–132. https://doi.org/10.1161/CIRCRESAHA.116.310069
Voigt N, Dobrev D (2011) Ion channel remodelling in atrial fibrillation. Eur Cardiol Rev. 7:97. https://doi.org/10.15420/ecr.2011.7.2.97
Voigt N, Dobrev D (2016) Atrial-selective potassium channel blockers. Card Electrophysiol Clin 8:411–421. https://doi.org/10.1016/j.ccep.2016.02.005
Wiedmann F, Schmidt C, Lugenbiel P, Staudacher I, Rahm AK, Seyler C, Schweizer PA, Katus HA, Thomas D (2016) Therapeutic targeting of two-pore-domain potassium (K2P) channels in the cardiovascular system. Clin Sci (Lond) 130:643–650. https://doi.org/10.1042/CS20150533
Acknowledgements
The excellent technical support of Katrin Kupser, Kai Sona and Stefanie Triebel is gratefully acknowledged. This study was supported in part by research grants from the University of Heidelberg, Faculty of Medicine (Rahel Goitein-Straus Scholarship and Olympia-Morata Scholarship to C. S.), from the DZHK (German Center for Cardiovascular Research; Excellence Grant to C. S.), from the German Cardiac Society and the Hengstberger Foundation (Klaus-Georg and Sigrid Hengstberger Scholarship to D. T.), from the German Heart Foundation/German Foundation of Heart Research (F/41/15 to C. S., F/08/14 to D.T.), from the Else Kröner-Fresenius-Stiftung (2014_A242 to D. T. and EKFS 2016_A20 to N. V.), from the Joachim Siebenreicher Foundation (to D. T.), from the Deutsche Forschungsgemeinschaft (German Research Foundation; SCHM 3358/1-1 to C. S., TH 1120/7-1 to D. T., MU 1376/11-3 to F. U. M and VO 1568/3-1, IRTG1816 RP12, SFB1002 TPA13 to N. V.), and from the Ministry of Science, Research and the Arts Baden-Wuerttemberg (Sonderlinie Medizin to D. T.). F. W. was supported by the German Cardiac Society (Fellowship and Otto-Hess-Scholarship), and A. R. was supported by the Kaltenbach-Scholarship of the German Heart Foundation/German Foundation of Heart Research.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethical standards
Animal experiments were carried out in accordance with the Guide for the Care and Use of Laboratory Animals as adopted and promulgated by the US National Institutes of Health (NIH publication No. 86-23, revised 1985) and with EU Directive 2010/63/EU, and the current version of the German Law on the Protection of Animals was followed. The manuscript does not contain clinical studies or patient data.
Conflict of interest
The authors declare that they have no conflict of interest.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Wiedmann, F., Schulte, J.S., Gomes, B. et al. Atrial fibrillation and heart failure-associated remodeling of two-pore-domain potassium (K2P) channels in murine disease models: focus on TASK-1. Basic Res Cardiol 113, 27 (2018). https://doi.org/10.1007/s00395-018-0687-9
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s00395-018-0687-9